CA2805132C - Purification de fragments d'anticorps - Google Patents

Purification de fragments d'anticorps Download PDF

Info

Publication number
CA2805132C
CA2805132C CA2805132A CA2805132A CA2805132C CA 2805132 C CA2805132 C CA 2805132C CA 2805132 A CA2805132 A CA 2805132A CA 2805132 A CA2805132 A CA 2805132A CA 2805132 C CA2805132 C CA 2805132C
Authority
CA
Canada
Prior art keywords
antibody fragment
chromatography
process according
cation exchange
exchange chromatography
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2805132A
Other languages
English (en)
Other versions
CA2805132A1 (fr
Inventor
Mariangela Spitali
Jonathan Symmons
Richard Whitcombe
Mark Robert Pearce-Higgins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Publication of CA2805132A1 publication Critical patent/CA2805132A1/fr
Application granted granted Critical
Publication of CA2805132C publication Critical patent/CA2805132C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/306—Extraction; Separation; Purification by precipitation by crystallization
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne un procédé de purification d'un fragment d'anticorps à partir d'un extrait cellulaire du périplasme comprenant une première étape de chromatographie échangeuse de cations et une seconde étape de chromatographie échangeuse d'anions.
CA2805132A 2010-07-27 2011-07-26 Purification de fragments d'anticorps Active CA2805132C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1012603.5A GB201012603D0 (en) 2010-07-27 2010-07-27 Protein purification
GB1012603.5 2010-07-27
PCT/EP2011/062837 WO2012013682A2 (fr) 2010-07-27 2011-07-26 Purification de protéines

Publications (2)

Publication Number Publication Date
CA2805132A1 CA2805132A1 (fr) 2012-02-02
CA2805132C true CA2805132C (fr) 2020-01-14

Family

ID=42752872

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2805132A Active CA2805132C (fr) 2010-07-27 2011-07-26 Purification de fragments d'anticorps

Country Status (23)

Country Link
US (4) US9309280B2 (fr)
EP (2) EP3747893A1 (fr)
JP (1) JP5893622B2 (fr)
KR (1) KR101921767B1 (fr)
CN (2) CN103025752A (fr)
AU (1) AU2011284896B2 (fr)
BR (1) BR112013000623B1 (fr)
CA (1) CA2805132C (fr)
CY (1) CY1123619T1 (fr)
DK (1) DK2598514T3 (fr)
ES (1) ES2834967T3 (fr)
GB (1) GB201012603D0 (fr)
HK (1) HK1246330A1 (fr)
HU (1) HUE052159T2 (fr)
IL (1) IL223931A (fr)
LT (1) LT2598514T (fr)
PL (1) PL2598514T3 (fr)
PT (1) PT2598514T (fr)
RS (1) RS61095B1 (fr)
SG (2) SG186957A1 (fr)
SI (1) SI2598514T1 (fr)
SM (1) SMT202000644T1 (fr)
WO (1) WO2012013682A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201012603D0 (en) * 2010-07-27 2010-09-08 Ucb Pharma Sa Protein purification
ES3011307T3 (en) 2012-02-23 2025-04-07 Juno Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
SG10201701224UA (en) * 2012-03-12 2017-04-27 Merck Patent Gmbh Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode
EP2864346B1 (fr) * 2012-06-21 2018-10-17 Synthon Biopharmaceuticals B.V. Procédé de purification d'un anticorps
CN112126634A (zh) * 2013-01-09 2020-12-25 夏尔人类遗传性治疗公司 含用于纯化芳基硫酸酯酶a的方法
EP2992021B1 (fr) * 2013-04-30 2020-07-22 Intas Pharmaceuticals Limited Nouveau procédé de clonage, d'expression et de purification pour la préparation de ranibizumab
JP6326499B2 (ja) 2013-12-12 2018-05-16 イー・エム・デイー・ミリポア・コーポレイシヨン アクリルアミド含有フィルターを使用したタンパク質分離
CN107108691B (zh) 2014-12-22 2021-06-29 Ucb生物制药私人有限公司 蛋白质制造方法
US11867696B2 (en) 2015-02-06 2024-01-09 Cell Idx, Inc. Antigen-coupled immunoreagents
MX2018004875A (es) 2015-10-22 2018-08-01 Juno Therapeutics Gmbh Metodos para cultivar celulas y kits y aparatos para ello.
EP3365453A2 (fr) 2015-10-22 2018-08-29 Juno Therapeutics GmbH Procédés, kits, agents et appareils de transduction
GB201602938D0 (en) 2016-02-19 2016-04-06 Ucb Biopharma Sprl Protein purification
CN109716130B (zh) * 2016-07-18 2023-05-23 赛尔伊迪克斯公司 抗原偶联的杂交试剂
WO2018119142A1 (fr) 2016-12-21 2018-06-28 Amgen Inc. Formulations d'anticorps anti-tnf alpha
JP7339160B2 (ja) 2017-04-27 2023-09-05 ジュノ セラピューティクス ゲーエムベーハー オリゴマー粒子試薬およびその使用方法
US10717023B1 (en) * 2017-10-11 2020-07-21 Roddy Kevin Stafford Method for continuous purification
CN110241012B (zh) * 2018-03-09 2022-11-01 嘉和生物药业有限公司 一种生物大分子上游分阶段截留的生产方法、生产模块及在生产中的应用
SG11202104355SA (en) 2018-10-31 2021-05-28 Juno Therapeutics Gmbh Methods for selection and stimulation of cells and apparatus for same
WO2021176311A1 (fr) * 2020-03-05 2021-09-10 Lupin Limited Procédé de purification amélioré de ranibizumab
EP4423109A4 (fr) 2021-10-27 2025-12-24 Plasma Tech Llc Compositions et procédés pour isoler des protéines
AU2023281650A1 (en) 2022-05-30 2024-10-17 Hanall Biopharma Co., Ltd. Anti-fcrn antibody or antigen binding fragment thereof with improved stability

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
US5655866A (en) 1995-03-20 1997-08-12 Bellanca; Joseph V. Method of folding a signature for use in bookbinding
DE69738075T2 (de) 1996-11-27 2008-05-21 Genentech, Inc., South San Francisco Affinitätsreinigung von polypeptiden an einer protein a-matrix
KR20010033601A (ko) * 1997-12-24 2001-04-25 다케다 야쿠힌 고교 가부시키가이샤 폴리펩티드, 그의 제법 및 용도
NZ507557A (en) 1998-05-06 2003-10-31 Genentech Inc Protein purification by ion exchange chromatography
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
WO2003102132A2 (fr) * 2002-04-26 2003-12-11 Genetech, Inc. Purification de proteines basee sur la non affinite
HUE033623T2 (en) 2002-09-11 2017-12-28 Genentech Inc protein purification
GB0224082D0 (en) * 2002-10-16 2002-11-27 Celltech R&D Ltd Biological products
AT412785B (de) * 2003-12-04 2005-07-25 Kungl Andreas J Dr Gag-bindungsproteine
EP1869065B1 (fr) * 2005-03-11 2020-05-06 Wyeth LLC Procede de chromatographie a faible separation
CA2645739A1 (fr) * 2006-03-20 2007-09-27 Medarex, Inc. Purification de proteines
CN102887955A (zh) * 2006-04-05 2013-01-23 艾博特生物技术有限公司 抗体纯化
US20080000431A1 (en) 2006-06-29 2008-01-03 Stephen Longo Dog leash assembly
ES2533266T5 (es) 2007-10-30 2018-04-18 Genentech, Inc. Purificación de anticuerpos mediante cromatografía de intercambio catiónico
WO2009135656A1 (fr) * 2008-05-06 2009-11-12 Lonza Biologics Plc. Procédé de purification d’anticorps à l’aide de la chromatographie de déplacement
BRPI0920572A8 (pt) * 2008-10-20 2015-10-27 Abbott Lab Inativação viral durante a purificação dos anticorpos
MX2011004198A (es) * 2008-10-20 2011-05-24 Abbott Lab Anticerpos que unen a il-12 y metodos para purificar los mismos.
GB201012603D0 (en) * 2010-07-27 2010-09-08 Ucb Pharma Sa Protein purification

Also Published As

Publication number Publication date
HK1246330A1 (zh) 2018-09-07
CY1123619T1 (el) 2022-03-24
SI2598514T1 (sl) 2021-01-29
SMT202000644T1 (it) 2021-01-05
WO2012013682A2 (fr) 2012-02-02
US20190135909A1 (en) 2019-05-09
JP2013532673A (ja) 2013-08-19
HUE052159T2 (hu) 2021-04-28
JP5893622B2 (ja) 2016-03-23
ES2834967T3 (es) 2021-06-21
WO2012013682A3 (fr) 2012-05-18
KR20130131307A (ko) 2013-12-03
KR101921767B1 (ko) 2018-11-23
CN103025752A (zh) 2013-04-03
DK2598514T3 (da) 2020-11-16
US9309280B2 (en) 2016-04-12
GB201012603D0 (en) 2010-09-08
PL2598514T3 (pl) 2021-03-08
SG10201802316VA (en) 2018-04-27
EP2598514B1 (fr) 2020-09-09
US11339214B2 (en) 2022-05-24
BR112013000623A2 (pt) 2016-05-24
CA2805132A1 (fr) 2012-02-02
US20130184439A1 (en) 2013-07-18
LT2598514T (lt) 2020-12-28
US10189897B2 (en) 2019-01-29
EP2598514A2 (fr) 2013-06-05
CN107793477A (zh) 2018-03-13
SG186957A1 (en) 2013-02-28
IL223931A (en) 2017-10-31
RS61095B1 (sr) 2020-12-31
US20220289832A1 (en) 2022-09-15
BR112013000623B1 (pt) 2022-10-11
PT2598514T (pt) 2020-12-15
US20160108119A1 (en) 2016-04-21
AU2011284896B2 (en) 2016-06-16
EP3747893A1 (fr) 2020-12-09
AU2011284896A1 (en) 2013-01-24

Similar Documents

Publication Publication Date Title
US20220289832A1 (en) Protein purification
US12516106B2 (en) Method for protein purification
CA3031469C (fr) Procedes de purification de proteines contenant des fragments fc
JP2013500244A (ja) 抗体製造の最適化
TW201522365A (zh) 純化抗體的方法
IL272807B2 (en) Method for purifying proteins
JP2012072091A (ja) 抗体の精製方法
Class et al. Inventors: Mariangela Spitali (Slough, GB) Jonathan Symmons (Slough, GB) Richard Whitcombe (Slough, GB) Mark Robert Pearce-Higgins (Slough, GB)
HK1184467A (en) Protein purification
HK1247624B (en) Method for protein purification
HK1247624A1 (en) Method for protein purification

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20160310

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 14TH ANNIV.) - STANDARD

Year of fee payment: 14

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250603

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250603